HIGHLIGHTS
- who: Joakim Bergman from the Department of Clinical Sciences, Umeå University, , Umeå have published the paper: Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS, in the Journal: (JOURNAL) of June/27,/2009
- what: In this study the levels of selected proteins in three compartments in people with multiple sclerosis (PMS) were compared. This study included 13 paired samples of lumbar and ventricular CSF obtained at the same follow-up visit. The study had several weaknesses, the major one being the small sample . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.